SUMMARY Several series have suggested that pulmonary function abnormalities are common in systemic lupus erythematosus. However, only isolated studies have attempted to relate these abnormalities to immunological aspects of the disease. In the present study respiratory symptoms, pulmonary function tests, and immunological data were reviewed in 22 patients with systemic lupus erythematosus. Seventeen subjects had either clinical evidence or abnormalities of lung function suggestive of pulmonary involvement. A restrictive ventilatory defect or reduction in pulmonary diffusing capacity for carbon monoxide was demonstrated in 14 of the patients only 4 of whom were dyspnoeic. There was no correlation between pulmonary involvement, co-existent renal lupus, and immunological abnormality.
manifestations, was graded from 0 to + + +. Zero represented no evidence of disease activity, + evidence of disease activity without major organ involvement or fever, + + evidence of major organ involvement, and + + + fever greater than 38°C and major organ involvement. Seventeen patients were receiving corticosteroids at the time of assessment in a daily dose of 10 to 15 mg.
PULMONARY FUNCTION TESTS
Static and dynamic lung volumes were measured using a standard vitalograph spirometer. Pulmonary diffusing capacity (transfer factor) measurement was carried out according to the method of Ogilvie et al. (1957) . The measured transfer factor values were corrected for changes in haemoglobin concentration and alveolar volume. The correction for alteration in haemoglobin concentration was made using the correction formula of Cotes et al. (1972) . In normalisation ofthe transfer factor for change in alveolar volume it has been assumed that a change in lung volume of 1 litre gives a change in transfer factor of 0 *867 mmol/kPa (Cotes and Hall, 1970) . The vital capacity and transfer factor were considered to be reduced if less than 80% of mean predicted.
ANTI-DNA ANTIBODIES Anti-native DNA antibodies were measured by the Farr assay and with C14-labelled E. coli native DNA (Radiochemical Centre, Amersham) as antigen (Hughes, 1971 (Beck, 1961) . RHEUMATOID FACTOR This was measured using the R3 titration test of Denver laboratories. (Table 2 ). In two of these (Cases 4 and 7), there was evidence of irreversible airways obstruction with a normal transfer factor although case 7 was a non-smoker. In the 14 other patients with abnormalities of respiratory function, 5 had reduced transfer factor alone and the remaining 9 had restrictive ventilatory defects in association with reduced transfer factor. In the latter group of 9 patients 4 were dyspnoeic but only 1 patient (case 14), had radiological evidence of interstitial fibrosis.
Results
The immunological data are summarised in Table  3 , along with the degree of system involvement. Anti-nuclear antibody was present in all sera in titres varying between 1/10 and 1/1000. Rheumatoid factor in a titre of 1/16 or greater was detected in 6 sera. Serum complement C4 levels in 21 sera tested were within the normal range in 7 group.bmj.com on October 21, 2017 -Published by http://ard.bmj.com/ Downloaded from impairment of transfer factor and this is in keeping with the findings of others (Edmonds et al., 1975) .
It has been suggested previously that patients with predominantly pulmonary involvement in SLE, had a low incidence of renal disease (Holgate et al., 1976) . In the group of patients investigated here no significant difference was found in the incidence of pleuro-pulmonary disease between those with and without renal involvement.
One of our patients (case 5), had no other clinical evidence of disease activity at the time of investigation, but had a raised DNA binding capacity and antinuclear antibodies in her serum. We would agree with others (Edmonds et al., 1975) 
